
  
    
      
        Background_NNP
        Phosphatidylinositol-_NNP (_( 3_CD ,_, 4_CD ,_, 5_LS )_) -_: trisphosphate_NN (_( PIP_NNP 3_LS )_) is_VBZ one_CD
        of_IN the_DT major_JJ intracellular_NN second_JJ messengers_NNS regulating_VBG
        growth_NN ,_, metabolism_NN and_CC vesicular_NN trafficking_NN [_NN for_IN reviews_NNS
        see_VBP refs_NNS [_NN 1_CD 2_CD 3_CD ]_NN ]_NN ._. The_DT level_NN of_IN (_( PIP_NNP 3_LS )_) in_IN the_DT cell_NN is_VBZ
        determined_VBN by_IN the_DT balance_NN of_IN kinase_NN and_CC phosphatase_NN
        activity_NN ._. PI-_NNP 3_CD Kinase_NNP activity_NN is_VBZ acutely_RB regulated_VBN and_CC a_DT
        number_NN of_IN isoforms_NNS have_VBP been_VBN cloned_VBN that_WDT are_VBP activated_VBN in_IN
        response_NN to_TO various_JJ stimuli_NNS [_NN 4_CD ]_NN ._. The_DT major_JJ
        phosphatidylinositol-_NN 3_CD -_: phosphate_NN phosphatase_NN in_IN cells_NNS is_VBZ
        the_DT tumor_NN suppressor_NN PTEN_NNP [_NN 5_CD 6_CD ]_NN ._. This_DT protein_NN has_VBZ a_DT
        tonic_NN inhibitory_NN effect_NN on_IN PI-_NNP 3_CD Kinase_NNP signaling_VBG by_IN
        reversing_VBG the_DT 3_CD '_POS -_: phosphorylation_NN ._. PTEN_NNP is_VBZ altered_VBN or_CC
        deleted_VBN in_IN many_JJ human_JJ cancers_NNS [_NN 7_CD 8_CD 9_CD 10_CD ]_NN ._. In-vitro_NNP ,_,
        cells_NNS that_WDT are_VBP deficient_NN in_IN PTEN_NNP show_NN elevated_VBD PI-_NNP 3_CD Kinase_NNP
        signaling_VBG [_NN 11_CD ]_NN ._. Reintroduction_NNP of_IN PTEN_NNP in_IN a_DT variety_NN of_IN
        cancer_NN cells_NNS ,_, including_VBG glioma_NN ,_, breast_NN ,_, bladder_NN and_CC ovarian_NN
        cancer_NN cells_NNS ,_, causes_NNS G_NNP 1_CD arrest_NN ,_, inhibits_NNS tumorigenesis_NNS ,_, and_CC
        promotes_VBZ anoikis_NNS [_NN 12_CD 13_CD 14_CD ]_NN ._. Mechanistically_NNP ,_, Akt_NNP
        activity_NN is_VBZ decreased_VBN ,_, cell_NN motility_NN is_VBZ decreased_VBN ,_,
        expression_NN of_IN two_CD cyclin-dependent_JJ kinase_NN inhibitors_NNS p_NN 27_CD
        and_CC p_NN 21_CD is_VBZ increased_VBN ,_, cyclin_NN D_NNP 1_CD is_VBZ down-regulated_JJ ,_, Rb_NNP
        phosphorylation_NN is_VBZ inhibited_VBD ,_, and_CC signaling_VBG via_IN Grb_NNP 2_CD /_NN SOS_NNP is_VBZ
        suppressed_VBN [_NN 11_CD 15_CD ]_NN ._. The_DT link_NN between_IN PTEN_NNP and_CC cell_NN
        growth_NN is_VBZ underscored_VBN by_IN genetic_JJ experiments_NNS in_IN mice_NNS ._. PTEN_NNP
        knockout_NN mice_NNS die_VBP in-utero_JJ due_NN to_TO extensive_JJ overgrowth_NN of_IN
        the_DT cephalic_JJ and_CC caudal_NN regions_NNS [_NN 12_CD 16_CD ]_NN ._. PTEN_NNP +_NN /_NN -_:
        heterozygous_JJ mice_NNS have_VBP a_DT predisposition_NN to_TO tumors_NNS in_IN
        multiple_JJ tissues_NNS often_RB with_IN loss_NN of_IN the_DT second_JJ allele_NN [_NN 17_CD
        18_CD ]_NN ._. In-vitro_NNP ,_, PTEN-_NNP /_NN -_: embryonic_JJ stem_NN cells_NNS and_CC
        fibroblasts_NNS display_VBP increased_VBD proliferation_NN and_CC decreased_VBD
        sensitivity_NN to_TO apoptosis_NNS ._.
        The_DT PI-_NNP 3_CD Kinase-dependent_NNP activation_NN of_IN Akt_NNP is_VBZ thought_VBN to_TO
        play_VB a_DT central_JJ role_NN in_IN the_DT cell_NN survival_NN pathway_NN in_IN many_JJ
        cells_NNS [_NN 7_CD 19_CD 20_CD ]_NN ._. Elevated_NNP Akt_NNP activity_NN and_CC protein_NN is_VBZ
        found_VBN in_IN many_JJ PTEN-deficient_NNP cancer_NN cells_NNS ._. Akt_NNP directly_RB
        phosphorylates_NNS and_CC inactivates_NNS the_DT pro-apoptotic_JJ proteins_NNS
        ASK_NNP 1_CD ,_, BAD_NNP ,_, caspase_NN 9_CD [_NN 21_CD 22_CD 23_CD 24_CD ]_NN ._. Akt_NNP also_RB induces_VBZ the_DT
        expression_NN of_IN the_DT anti-apoptotic_JJ Bcl-_NNP 2_CD and_CC c-_NN FLIP_NNP proteins_NNS ,_,
        and_CC suppresses_NNS the_DT cell_NN cycle_NN inhibitor_NN p_NN 27_CD KIP_NNP [_NN 25_CD 26_CD 27_CD
        28_CD ]_NN ._. This_DT later_JJ effect_NN is_VBZ via_IN the_DT phosphorylation_NN and_CC
        inactivation_NN of_IN the_DT forkhead_NN family_NN of_IN transcription_NN
        factors_NNS AFX_NNP ,_, FKHR_NNP and_CC FKHR-L_NNP 1_CD ._. Although_IN it_PRP is_VBZ often_RB assumed_VBN
        that_WDT elevated_VBD Akt_NNP activity_NN is_VBZ responsible_JJ for_IN the_DT increased_VBN
        survival_NN of_IN cancer_NN cells_NNS ,_, Akt_NNP activity_NN is_VBZ not_RB the_DT only_JJ
        pathway_NN that_WDT is_VBZ essential_JJ for_IN cell_NN survival_NN ._. The_DT MAPK_NNP
        pathway_NN can_MD also_RB protect_VB cells_NNS from_IN apoptosis_NNS ,_, as_IN can_MD
        constitutive_JJ activation_NN of_IN Stat_NNP 3_CD signaling_VBG [_NN 29_CD 30_CD ]_NN ._.
        The_DT IGF-I_NNP Receptor_NNP is_VBZ a_DT member_NN of_IN the_DT large_JJ family_NN of_IN
        tyrosine_NN kinase_NN growth_NN factor_NN receptors_NNS ._. Signaling_NNP by_IN the_DT
        IGF-IR_NNP has_VBZ been_VBN studied_VBN in_IN many_JJ different_JJ cell_NN types_NNS and_CC is_VBZ
        important_JJ for_IN proliferation_NN ,_, survival_NN ,_, motility_NN ,_, adhesion_NN ,_,
        transformation_NN ,_, tumor_NN formation_NN and_CC metastasis_NNS [_NN for_IN reviews_NNS
        see_VBP refs_NNS [_NN 31_CD 32_CD ]_NN ]_NN ._. The_DT receptor_NN can_MD directly_RB
        phosphorylate_NN the_DT insulin_NN receptor_NN substrate_NN 1_CD (_( IRS-_NNP 1_LS )_) and_CC
        Shc_NNP proteins_NNS in_IN the_DT intact_JJ cell_NN causing_VBG activation_NN of_IN
        PI-_NNP 3_CD Kinase_NNP and_CC ras_NNS signaling_VBG [_NN 33_CD ]_NN ._. More_RBR recently_RB ,_, it_PRP has_VBZ
        been_VBN shown_VBN that_IN the_DT IGF-IR_NNP signals_NNS via_IN the_DT Gβγ_NNP subunits_NNS of_IN
        the_DT heterotrimeric_JJ Gi_NNP complex_JJ to_TO stimulate_VB PI-_NNP 3_CD Kinase_NNP and_CC
        ras_NNS ,_, and_CC also_RB activates_NNS the_DT JAK_NNP /_NN Stat_NNP pathway_NN to_TO cause_VB
        phosphorylation_NN of_IN Stat_NNP 3_CD [_NN 34_CD 35_CD ]_NN ._.
        What_WP is_VBZ the_DT evidence_NN for_IN the_DT involvement_NN of_IN IGF-IR_NNP
        signaling_VBG in_IN proliferation_NN and_CC cancer_NN ?_. Elegant_NNP studies_NNS in_IN
        knockout_NN mice_NNS have_VBP delineated_JJ the_DT contribution_NN of_IN IGF-I_NNP ,_,
        IGF-II_NNP and_CC the_DT IGF-I_NNP receptor_NN to_TO fetal_JJ growth_NN [_NN for_IN review_NN
        see_VB ref_NN [_NN 36_CD ]_NN ]_NN ._. Embryonic_NNP fibroblasts_NNS derived_VBN from_IN IGF-IR_NNP
        knockout_NN embryos_NNS (_( R-_NNP cells_NNS )_) do_VBP not_RB grow_VB in_IN serum-free_JJ
        medium_NN ,_, despite_IN supplementation_NN with_IN a_DT wide_JJ variety_NN of_IN
        other_JJ growth_NN factors_NNS ,_, and_CC grow_VB more_RBR slowly_RB in_IN media_NNS
        containing_VBG serum_NN than_IN wild-type_JJ cells_NNS [_NN for_IN reviews_NNS see_VBP refs_NNS
        [_NN 37_CD 38_CD ]_NN ]_NN ._. Additionally_RB ,_, all_DT phases_NNS of_IN the_DT cell_NN cycle_NN are_VBP
        prolonged_JJ in_IN the_DT null_NN cells_NNS suggesting_VBG that_IN the_DT IGF-IR_NNP is_VBZ
        required_VBN throughout_IN the_DT cell_NN cycle_NN ._. A_DT functional_JJ IGF-I_NNP
        receptor_NN is_VBZ required_VBN for_IN successful_JJ cell_NN transformation_NN ._.
        IGF-IR-_NNP /_NN -_: cells_NNS are_VBP not_RB transformed_VBN by_IN overexpression_NN of_IN
        SV_NNP 40_CD T_NN antigen_NN ,_, activated_VBN 
        ras_NNS ,_, or_CC EGF_NNP or_CC PDGF_NNP receptors_NNS ._.
        Transformation_NNP appears_VBZ to_TO involve_VB autocrine_NN stimulation_NN as_IN
        IGF-I_NNP production_NN and_CC secretion_NN is_VBZ increased_VBN in_IN normal_JJ cells_NNS
        following_VBG transformation_NN by_IN SV_NNP 40_CD T_NN antigen_NN ,_, but_CC the_DT null_NN
        cells_NNS cannot_NN respond_NN to_TO the_DT IGF-I_NNP so_RB do_VBP not_RB transform_VB ._.
        Interfering_NNP with_IN the_DT IGF_NNP signaling_VBG system_NN can_MD inhibit_VB
        the_DT growth_NN of_IN cancer_NN cells_NNS in-vitro_JJ and_CC in-vivo_JJ ._. Treatment_NNP
        with_IN antagonistic_JJ peptide_NN analogs_NNS of_IN IGF-I_NNP ,_, antisense_NN
        oligos_NNS ,_, or_CC an_DT adenovirus_JJ expressing_VBG IGF-IR_NNP antisense_NN cRNA_NN ,_,
        prevents_VBZ proliferation_NN of_IN cells_NNS in_IN monolayers_NNS ,_,
        transformation_NN ,_, and_CC growth_NN in_IN athymic_JJ nude_JJ mice_NNS ._. This_DT
        includes_VBZ multiple_JJ human_JJ tumor_NN cell_NN lines_NNS including_VBG
        glioblastoma_NN ,_, melanoma_NN ,_, ovarian_NN carcinoma_NN ,_, prostatic_JJ
        carcinoma_NN ,_, and_CC breast_NN carcinomas_NNS )_) ._. [_NN for_IN reviews_NNS see_VBP refs_NNS [_NN
        31_CD ]_NN ,_, [_NN 39_CD 40_CD 41_CD ]_NN ]_NN ._. The_DT IGF-IR_NNP appears_VBZ to_TO function_VB in_IN
        transformation_NN both_DT by_IN preventing_VBG apoptosis_NNS through_IN
        activation_NN of_IN Akt_NNP and_CC by_IN stimulating_VBG proliferation_NN through_IN
        the_DT ras-_NN MAPK_NNP cascade_NN ._. IGF-I_NNP can_MD prevent_VB 
        c-myc_JJ -_: induced_VBN apoptosis_NNS in_IN rat-l_JJ
        fibroblasts_NNS ,_, and_CC neuronal_NN apoptosis_NNS due_JJ to_TO
        serum-starvation_JJ ._. IGF-IR-_NNP /_NN -_: cells_NNS can_MD proliferate_VBP in_IN
        monolayers_NNS in_IN the_DT presence_NN of_IN serum_NN but_CC undergo_VBP apoptosis_NNS
        when_WRB put_VB in_IN suspension_NN and_CC are_VBP more_RBR sensitive_JJ to_TO
        chemotherapeutic_JJ reagents_NNS ._. There_EX is_VBZ also_RB evidence_NN
        implicating_VBG the_DT IGF-IR_NNP in_IN metastasis_NNS ._. IGF-I_NNP produces_VBZ a_DT
        chemotactic_JJ response_NN in_IN human_JJ melanoma_NN cells_NNS and_CC antisense_NN
        to_TO the_DT IGF-IR_NNP mRNA_NN prevents_VBZ metastasis_NNS in_IN the_DT murine_NN
        carcinoma_NN cell_NN H-_NNP 59_CD ._.
        In_IN this_DT study_NN ,_, we_PRP wanted_VBD to_TO determine_VB if_IN disruption_NN of_IN
        IGF-I_NNP signaling_VBG could_MD prevent_VB growth_NN of_IN a_DT tumor_NN cell_NN
        lacking_VBG PTEN_NNP ._. Elevated_NNP PI-_NNP 3_CD Kinase_NNP can_MD be_VB normalized_JJ by_IN
        reintroduction_NN of_IN PTEN_NNP to_TO reduce_VB PIP_NNP 3_CD levels_NNS ,_, but_CC it_PRP has_VBZ
        not_RB been_VBN shown_VBN that_IN this_DT effect_NN can_MD also_RB be_VB achieved_VBN by_IN
        disruption_NN of_IN an_DT upstream_JJ signal_NN that_IN stimulates_NNS PI-_NNP 3_CD Kinase_NNP
        activity_NN ._. We_PRP have_VBP previously_RB demonstrated_VBN the_DT
        overexpression_NN and_CC hormone-independent_JJ activation_NN of_IN the_DT
        IGF-IR_NNP in_IN primary_JJ breast_NN cancers_NNS [_NN 42_CD ]_NN ._. Similar_JJ
        overexpression_NN of_IN the_DT IGF-IR_NNP and_CC the_DT ligands_NNS IGF-I_NNP and_CC
        IGF-II_NNP have_VBP been_VBN seen_VBN in_IN human_JJ gliomas_NNS and_CC astrocytomas_NNS [_NN
        43_CD 44_CD 45_CD 46_CD ]_NN ._. Because_IN of_IN the_DT important_JJ role_NN for_IN the_DT
        IGF-IR_NNP in_IN cell_NN survival_NN ,_, we_PRP investigated_VBD whether_IN a_DT dominant_JJ
        negative_JJ IGF-IR_NNP could_MD inhibit_VB growth_NN of_IN the_DT U_NNP 87_CD glioma_NN ._.
        This_DT glioma_NN is_VBZ deficient_NN in_IN PTEN_NNP and_CC shows_VBZ constitutive_JJ
        activation_NN of_IN Akt_NNP ,_, which_WDT can_MD be_VB inactivated_JJ by_IN
        re-introduction_JJ of_IN PTEN_NNP [_NN 47_CD ]_NN ._.
      
      
        Materials_NNS and_CC Methods_NNP
        
          Materials_NNS and_CC Cell_NNP Culture_NNP
          Antiphosphotyrosine_NNP antibodies_NNS (_( pY_NN 20_CD )_) were_VBD from_IN
          BD-Transduction_NNP Labs_NNPS (_( Lexington_NNP ,_, KY_NNP )_) ._. Matrigel_NNP was_VBD from_IN
          Becton-_NNP Dickinson_NNP (_( Bedford_NNP ,_, MA_NNP )_) Athymic_NNP nude_JJ mice_NNS were_VBD
          purchased_VBN from_IN Charles_NNP River_NNP (_( Wilmington_NNP ,_, MA_NNP )_) ._. Enhanced_NNP
          chemiluminescence_NN reagents_NNS were_VBD from_IN Amersham_NNP
          (_( Piscataway_NNP ,_, NJ_NNP )_) ._. [_NN 3_CD H_NNP ]_NN -_: thymidine_NN (_( 20_CD Ci_NNP /_NN mmol_NN )_) was_VBD from_IN
          Perkin-_NNP Elmer_NNP /_NN NEN_NNP Life_NNP Sciences_NNPS (_( Boston_NNP ,_, MA_NNP )_) ._. Unless_IN
          noted_VBD ,_, all_DT other_JJ reagents_NNS were_VBD supplied_VBN by_IN Sigma_NNP Chemical_NNP
          Co_NNP ._. (_( St_NNP ._. Louis_NNP ,_, MO_NNP )_) or_CC Fisher_NNP Scientific_NNP Co_NNP ._.
          (_( Springfield_NNP ,_, NJ_NNP )_) ._. CHO_NNP cells_NNS were_VBD maintained_VBN in_IN Hams_NNP F_NNP 12_CD
          with_IN 25_CD mM_NN glucose_NN with_IN 50_CD units_NNS /_NN ml_NN penicillin_NN ,_, 50_CD μg_NN /_NN ml_NN
          streptomycin_NN ,_, and_CC 10_CD %_NN FCS_NNP in_IN a_DT 10_CD %_NN CO_NNP 
          2_CD environment_NN ._. U_NNP 87_CD glioma_NN cells_NNS were_VBD
          maintained_VBN in_IN MEM-Earle_NNP 's_POS medium_NN with_IN non-essential_JJ amino_JJ
          acids_NNS ,_, 1_CD mM_NN sodium_NN pyruvate_NN ,_, 10_CD %_NN FCS_NNP ,_, 2_CD mM_NN Glutamax_NNP and_CC
          gentamycin_NN sulphate_NN in_IN a_DT 10_CD %_NN CO_NNP 2_CD environment_NN ._.
        
        
          Immunoblotting_NNP
          Cells_NNP were_VBD serum_NN starved_VBN for_IN 16_CD h_NN in_IN 12_CD -_: well_RB plates_NNS ,_,
          then_RB stimulated_VBN with_IN IGF-I_NNP (_( 10_CD or_CC 100_CD ng_NN /_NN ml_NN )_) for_IN 5_CD min_NN at_IN
          37_CD °_NN C_NNP ._. The_DT cells_NNS were_VBD washed_VBN with_IN ice-cold_JJ
          phosphate-buffered_JJ saline_NN and_CC solubilized_JJ in_IN 2_CD ×_NN
          SDS-sample_NNP buffer_NN containing_VBG 2_CD mM_NN sodium_NN orthovanadate_NN
          and_CC 200_CD mM_NN sodium_NN fluoride_NN ._. The_DT proteins_NNS were_VBD denatured_JJ
          by_IN boiling_VBG for_IN 5_CD min_NN ,_, then_RB were_VBD separated_VBN by_IN
          electrophoresis_NNS on_IN 7_CD ._. 5_CD %_NN SDS-PAGE_NNP ,_, and_CC transferred_VBD to_TO PVDF_NNP
          membranes_NNS ._. The_DT filter_NN was_VBD blocked_VBN with_IN 3_CD %_NN BSA_NNP in_IN TBS_NNP with_IN
          0_CD ._. 1_CD %_NN Tween_NNP 20_CD (_( T-TBS_NNP )_) for_IN 30_CD min_NN and_CC incubated_JJ with_IN the_DT
          anti-phosphotyrosine_JJ antibodies_NNS at_IN a_DT dilution_NN of_IN 1_CD :_: 1000_CD ._.
          The_DT filters_NNS were_VBD washed_VBN with_IN T-TBS_NNP for_IN 30_CD min_NN and_CC
          incubated_JJ with_IN horseradish-peroxidase_JJ conjugated_JJ
          secondary_JJ antibodies_NNS ,_, and_CC tyrosine-phosphorylated_JJ
          proteins_NNS were_VBD visualized_JJ by_IN enhanced_JJ
          chemiluminescence_NN ._.
        
        
          Measurement_NNP of_IN thymidine_NN incorporation_NN
          Cells_NNP were_VBD grown_VBN to_TO 75_CD %_NN confluence_NN in_IN six-well_JJ cluster_NN
          plates_NNS ._. The_DT growth_NN medium_NN was_VBD replaced_VBN with_IN serum-free_JJ
          Ham_NNP 's_POS F_NN 12_CD for_IN 36_CD h_NN ._. Cells_NNP were_VBD stimulated_VBN with_IN IGF-I_NNP at_IN
          the_DT indicated_VBN concentrations_NNS for_IN 18_CD h_NN ._. Cells_NNP were_VBD pulsed_JJ
          with_IN [_NN 3_CD H_NNP ]_NN -_: thymidine_NN ,_, 2_CD μCi_NN /_NN ml_NN ,_, for_IN 1_CD h_NN at_IN 37_CD °_NN C_NNP ._. The_DT
          cells_NNS were_VBD washed_VBN five_CD times_NNS in_IN PBS_NNP ,_, solubilized_JJ ,_, the_DT DNA_NNP
          precipitated_VBD with_IN 10_CD %_NN trichloroacetic_JJ acid_NN at_IN 4_CD °_NN C_NNP ,_, and_CC
          counted_VBD in_IN an_DT scintillation_NN counter_NN ._.
        
        
          Production_NN of_IN pseudo-typed_JJ retrovirus_JJ
          The_DT wild-type_JJ IGF-IR_NNP cDNA_NN or_CC a_DT mutant_JJ cDNA_NN ,_, which_WDT
          contained_VBD a_DT methionine_NN substitution_NN for_IN lysine_NN 1003_CD in_IN
          the_DT ATP-binding_NNP site_NN of_IN the_DT kinase_NN domain_NN ,_, were_VBD cloned_VBN
          into_IN the_DT retroviral_NN vector_NN pLPONL_NN [_NN 57_CD ]_NN ._. The_DT
          pseudo-typed_JJ viruses_NNS were_VBD generated_VBN and_CC purified_JJ by_IN the_DT
          UCSD_NNP Viral_NNP Vector_NNP Core_NNP ._. The_DT plasmids_NNS were_VBD co-transfected_JJ
          into_IN 293_CD cells_NNS with_IN an_DT expression_NN vector_NN for_IN the_DT
          Vesicular_NNP Stomatitis_NNP Virus-_NNP G_NNP protein_NN ._. This_DT coat_NN protein_NN
          allows_VBZ the_DT virus_NN to_TO be_VB concentrated_VBN and_CC confers_VBZ greater_JJR
          tropism_NN ._. Cell_NNP culture_NN supernatants_NNS and_CC cells_NNS were_VBD
          harvested_VBN and_CC the_DT virus_NN concentrated_VBN ._. Viruses_NNP were_VBD
          titered_JJ on_IN NIH_NNP 3_CD T_NN 3_CD cells_NNS and_CC the_DT number_NN of_IN G_NNP 418_CD resistant_JJ
          colonies_NNS counted_VBN ._. A_DT control_NN virus_NN containing_VBG the_DT E_NNP ._. coli_NNS
          β-galactosidase_JJ gene_NN was_VBD obtained_VBN from_IN the_DT Viral_NNP Vector_NNP
          Core_NNP ._.
        
        
          Growth_NN in_IN Soft_NNP Agar_NNP
          Cells_NNP were_VBD trypsinized_JJ and_CC 10_CD 4_CD cells_NNS plated_JJ in_IN 35_CD mm_NN
          petri_NN dishes_NNS in_IN complete_JJ medium_NN containing_VBG 0_CD ._. 35_CD %_NN agarose_NN
          over_IN a_DT layer_NN of_IN 0_CD ._. 7_CD %_NN agarose_NN in_IN complete_JJ medium_NN ._. Cells_NNP
          were_VBD allowed_VBN to_TO grow_VB for_IN 14_CD -_: 21_CD days_NNS or_CC until_IN colonies_NNS
          were_VBD >_NN 125_CD μm_NN in_IN diameter_NN ._. Fresh_NNP medium_NN was_VBD layered_JJ
          above_IN the_DT agarose_NN every_DT 3_CD -_: 5_CD days_NNS ._. Colonies_NNP were_VBD stained_JJ
          with_IN Crystal_NNP Violet_NNP and_CC counted_VBN ._.
        
        
          Tumor_NNP Growth_NNP in_IN Athymic_NNP Nude_NNP Mice_NNS
          Housing_NNP and_CC all_DT procedures_NNS using_VBG nude_JJ mice_NNS were_VBD
          approved_VBN by_IN the_DT animal_NN care_NN committee_NN at_IN UCSD_NNP ._. The_DT cells_NNS
          for_IN injection_NN were_VBD trypsinized_JJ in_IN sterile_JJ PBS_NNP ,_, pelleted_JJ
          by_IN centrifugation_NN at_IN 300_CD ×_NN g_SYM for_IN 2_CD min_NN ._. and_CC washed_VBN twice_RB
          in_IN sterile_JJ saline_NN ._. Cells_NNP were_VBD resuspended_JJ in_IN 100_CD μl_NN
          sterile_JJ saline_NN and_CC counted_VBN using_VBG a_DT hemacytometer_NN ._. The_DT
          appropriate_JJ number_NN of_IN cells_NNS was_VBD diluted_VBN into_IN 50_CD μl_NN
          sterile_JJ saline_NN and_CC then_RB added_VBD to_TO an_DT equal_JJ volume_NN of_IN
          sterile_JJ Matrigel_NNP on_IN ice_NN ._. This_DT suspension_NN was_VBD injected_VBN
          subcutaneously_RB on_IN the_DT rear_JJ flank_NN of_IN athymic_JJ nude_JJ mice_NNS
          using_VBG a_DT sterile_JJ syringe_NN and_CC 22_CD -_: gauge_VB needle_NN ._. Mice_NNS were_VBD
          observed_VBN on_IN a_DT twice-weekly_JJ basis_NN to_TO check_VB for_IN tumor_NN
          growth_NN ._. Tumors_NNP were_VBD measured_VBN with_IN calipers_NNS in_IN three_CD
          dimensions_NNS and_CC tumor_NN volume_NN calculated_VBD assuming_VBG the_DT
          tumors_NNS were_VBD ellipsoid_NN ._. At_IN the_DT end_NN of_IN the_DT study_NN ,_, the_DT
          tumors_NNS were_VBD excised_VBN ,_, measured_VBN ,_, weighed_VBD ,_, and_CC then_RB fixed_VBN in_IN
          10_CD %_NN formalin_NN ._. Tumors_NNP were_VBD embedded_VBN in_IN paraffin_NN ,_, sectioned_JJ
          and_CC stained_JJ with_IN hematoxylin-eosin_JJ or_CC for_IN apoptosis_NNS using_VBG
          the_DT TUNEL_NNP assay_NN (_( Roche_NNP ,_, Indianapolis_NNP ,_, IN_IN )_) ._.
        
      
      
        Results_NNS and_CC Discussion_NNP
        
          Inhibition_NNP of_IN the_DT IGF-I_NNP receptor_NN by_IN expression_NN of_IN a_DT
          kinase_NN inactive_JJ mutant_JJ inhibits_NNS proliferation_NN of_IN Chinese_JJ
          hamster_NN ovary_JJ (_( CHO_NNP )_) cells_NNS
          Before_IN embarking_VBG on_IN studies_NNS in_IN human_JJ tumor_NN cells_NNS ,_, we_PRP
          verified_VBN that_IN our_PRP$ dominant_JJ negative_JJ approach_NN would_MD work_VB
          in_IN a_DT model_NN system_NN ._. To_TO inhibit_VB the_DT IGF-IR_NNP ,_, we_PRP took_VBD
          advantage_NN of_IN the_DT fact_NN that_IN the_DT IGF-I_NNP receptor_NN is_VBZ a_DT
          hetero-tetramer_JJ ._. Activation_NNP of_IN the_DT native_JJ receptor_NN
          requires_VBZ the_DT trans-phosphorylation_JJ of_IN two_CD kinase_NN domains_NNS
          [_NN 48_CD ]_NN ._. Hence_RB ,_, expression_NN of_IN an_DT excess_NN of_IN
          kinase-defective_JJ IGF-I_NNP receptors_NNS causes_VBZ the_DT formation_NN of_IN
          hybrid_JJ molecules_NNS containing_VBG one_CD half_PDT an_DT endogenous_JJ
          wild-type_JJ receptor_NN and_CC the_DT other_JJ half_PDT a_DT kinase-defective_JJ
          transfected_JJ receptor_NN ._. These_DT hybrids_NNS should_MD be_VB kinase_NN
          inactive_JJ and_CC signaling_VBG incompetent_JJ ._. Similar_JJ approaches_NNS
          have_VBP been_VBN used_VBN successfully_RB in_IN other_JJ studies_NNS [_NN 49_CD 50_CD 51_CD
          52_CD ]_NN ._.
          Initially_RB ,_, we_PRP tested_VBD Chinese_JJ hamster_NN ovary_JJ (_( CHO_NNP )_) cells_NNS
          that_WDT had_VBD been_VBN stably_RB transfected_JJ with_IN expression_NN vectors_NNS
          for_IN kinase-inactive_JJ or_CC wild_JJ type_NN IGF-I_NNP receptors_NNS [_NN 53_CD ]_NN ._.
          The_DT parental_JJ CHO_NNP cell_NN line_NN expresses_VBZ ~_NN 50_CD ,_, 000_CD endogenous_JJ
          IGF-IRs_NNP ,_, the_DT transfected_JJ wild-type_JJ (_( CHO-WT_NNP )_) cell_NN line_NN
          expresses_VBZ ~_NN 250_CD ,_, 000_CD IGF-IRs_NNP ,_, and_CC the_DT kinase-defective_JJ
          (_( CHO-MK_NNP )_) cell_NN line_NN expresses_VBZ ~_NN 250_CD ,_, 000_CD mutant_JJ IGF-IRs_NNP ._.
          Thus_RB ,_, the_DT transfected_JJ cells_NNS express_VBP the_DT human_JJ IGF-IR_NNP at_IN
          approximately_RB five_CD fold_VB higher_JJR levels_NNS than_IN the_DT endogenous_JJ
          receptor_NN ._. The_DT mutant_JJ receptor_NN contains_VBZ a_DT lysine_NN to_TO
          methionine_NN (_( MK_NNP )_) point_NN mutation_NN at_IN position_NN 1003_CD in_IN the_DT
          ATP_NNP binding_JJ site_NN of_IN the_DT kinase_NN domain_NN and_CC has_VBZ no_DT
          measurable_JJ kinase_NN activity_NN ._. Two_CD clonal_NN lines_NNS expressing_VBG
          the_DT MK_NNP receptor_NN were_VBD used_VBN with_IN identical_JJ results_NNS ._.
          We_PRP assessed_VBD the_DT ability_NN of_IN the_DT IGF-IRs_NNP of_IN each_DT cell_NN
          line_NN to_TO undergo_VB autophosphorylation_NN in_IN response_NN to_TO
          increasing_VBG concentrations_NNS of_IN IGF-I_NNP ._. Cells_NNP were_VBD stimulated_VBN
          with_IN increasing_VBG concentrations_NNS of_IN IGF-I_NNP ,_, and_CC whole_JJ cell_NN
          lysates_NNS immunoblotted_JJ for_IN tyrosine-phosphorylated_JJ
          proteins_NNS ._. As_IN expected_VBN ,_, autophosphorylation_NN of_IN the_DT IGF-IRs_NNP
          was_VBD observed_VBN in_IN the_DT CHO_NNP and_CC CHO-WT_NNP cells_NNS but_CC very_RB little_RB
          was_VBD seen_VBN in_IN two_CD different_JJ clones_NNS of_IN CHO-MK_NNP cells_NNS ,_,
          indicating_VBG that_IN the_DT kinase-defective_JJ receptors_NNS inhibited_VBD
          the_DT endogenous_JJ wild-type_JJ hamster_NN receptors_NNS (_( Figure_NN 1_CD A_DT )_) ._.
          The_DT inhibition_NN was_VBD not_RB complete_JJ however_RB ,_, as_IN
          phosphorylation_NN of_IN IRS_NNP 1_CD ,_, the_DT major_JJ endogenous_JJ substrate_NN
          in_IN these_DT cells_NNS ,_, is_VBZ still_RB preserved_VBN at_IN the_DT higher_JJR dose_NN of_IN
          IGFI_NNP but_CC inhibited_VBD at_IN the_DT lower_JJR dose_NN ._. This_DT is_VBZ likely_JJ due_NN
          to_TO the_DT level_NN of_IN receptor_NN expression_NN ._. The_DT transfected_JJ
          receptors_NNS are_VBP expressed_VBN at_IN four_CD fold_VB the_DT level_NN of_IN the_DT
          endogenous_JJ receptors_NNS ._. Assuming_VBG stochastic_JJ assembly_NN of_IN
          tetramers_NNS ,_, 4_CD %_NN of_IN receptors_NNS should_MD be_VB homodimers_NNS of_IN
          signaling_VBG competent_JJ receptors_NNS that_WDT can_MD phosphorylate_NN
          IRS_NNP 1_CD ._. To_TO confirm_VB that_IN the_DT kinase-defective_JJ receptors_NNS were_VBD
          functioning_VBG in_IN a_DT dominant-negative_JJ fashion_NN ,_, we_PRP studied_VBD
          the_DT ability_NN of_IN CHO_NNP and_CC CHO-MK_NNP cells_NNS to_TO incorporate_VB
          3_CD H-_NNP thymidine_NN into_IN DNA_NNP in_IN response_NN to_TO IGF-I_NNP stimulation_NN ._.
          Serum-starved_NNP cells_NNS were_VBD stimulated_VBN with_IN increasing_VBG
          concentrations_NNS if_IN IGF-I_NNP and_CC then_RB pulsed_JJ with_IN
          3_CD H-_NNP thymidine_NN ._. The_DT ability_NN of_IN the_DT CHO-MK_NNP cells_NNS to_TO
          incorporate_VB thymidine_NN in_IN response_NN to_TO IGF-I_NNP is_VBZ markedly_RB
          diminished_VBN as_IN compared_VBN to_TO the_DT parental_JJ cell_NN line_NN (_( Figure_NN
          1_CD B_NNP )_) ._.
          We_PRP then_RB tested_VBD colony_NN formation_NN in_IN soft_JJ agar_NN as_IN an_DT
          indicator_NN of_IN cellular_JJ transformation_NN ._. Cells_NNP were_VBD
          trypsinized_JJ ,_, counted_VBN and_CC equivalent_NN numbers_NNS of_IN cells_NNS
          plated_JJ in_IN soft_JJ agar_NN in_IN complete_JJ medium_NN ._. Cells_NNP were_VBD
          cultured_JJ for_IN 14_CD -_: 21_CD days_NNS and_CC then_RB the_DT number_NN of_IN colonies_NNS
          counted_VBN ._. Overexpression_NNP of_IN the_DT wild-type_JJ IGF-IRs_NNP
          increased_VBD the_DT number_NN of_IN colonies_NNS ,_, and_CC overexpressing_VBG the_DT
          kinase-defective_JJ receptors_NNS reduced_VBD the_DT number_NN of_IN colonies_NNS
          by_IN 60_CD %_NN (_( Figure_NN 1_CD C_NNP )_) ._. Not_RB only_RB did_VBD we_PRP observe_VB a_DT difference_NN
          of_IN the_DT number_NN of_IN colonies_NNS ,_, but_CC CHO-MK_NNP colonies_NNS were_VBD
          smaller_JJR than_IN either_DT the_DT parental_JJ CHO_NNP or_CC CHO-WT_NNP colonies_NNS
          (_( data_NNS not_RB shown_VBN )_) ._.
          We_PRP next_RB studied_VBD the_DT ability_NN of_IN each_DT of_IN these_DT cell_NN
          lines_NNS to_TO form_VB tumors_NNS in_IN athymic_JJ nude_JJ mice_NNS ._. Ten_CD million_CD
          (_( 10_CD 7_CD )_) cells_NNS from_IN each_DT cell_NN line_NN were_VBD injected_VBN
          subcutaneously_RB into_IN the_DT flanks_NNS of_IN five_CD athymic_JJ nude_JJ mice_NNS ._.
          Tumor_NNP size_NN was_VBD measured_VBN biweekly_RB ._. The_DT mice_NNS were_VBD
          euthanized_JJ at_IN the_DT end_NN of_IN three_CD weeks_NNS and_CC the_DT tumors_NNS
          excised_VBD and_CC weighed_VBD (_( Figure_NN 1_CD D_NNP &_CC 1_CD E_NNP )_) ._. At_IN this_DT high_JJ
          level_NN of_IN innoculum_NN ,_, there_EX was_VBD no_DT difference_NN in_IN tumor_NN
          incidence_NN (_( data_NNS not_RB shown_VBN )_) ._. However_RB ,_, expression_NN of_IN the_DT
          wild-type_JJ IGF-IR_NNP accelerated_VBD tumor_NN growth_NN and_CC tumors_NNS were_VBD
          larger_JJR at_IN sacrifice_NN ._. The_DT kinase_NN defective_JJ IGF-IR_NNP ,_, on_IN the_DT
          other_JJ hand_NN ,_, delayed_VBD the_DT appearance_NN of_IN tumors_NNS and_CC smaller_JJR
          tumors_NNS were_VBD found_VBN at_IN sacrifice_NN ._.
          The_DT tumors_NNS were_VBD imbedded_JJ in_IN paraffin_NN and_CC sections_NNS were_VBD
          stained_JJ with_IN hematoxylin_NN and_CC eosin_NN (_( Figure_NN 2_CD ,_, left_VBD
          panels_NNS )_) ._. The_DT sections_NNS were_VBD also_RB stained_JJ for_IN the_DT presence_NN
          of_IN apoptosis_NNS using_VBG the_DT TUNEL_NNP method_NN ._. Apoptotic_NNP cells_NNS
          image_NN as_IN fluorescent_NN green_JJ (_( Figure_NN 2_CD ,_, right_JJ panels_NNS )_) ._. The_DT
          typical_JJ histology_NN of_IN CHO_NNP tumors_NNS is_VBZ shown_VBN in_IN panel_NN A_DT ._.
          Cells_NNP transfected_JJ with_IN the_DT wild-type_JJ IGF-IR_NNP have_VBP a_DT more_JJR
          streaming_VBG morphology_NN characteristic_NN of_IN human_JJ ovarian_NN
          tumors_NNS (_( Panel_NNP B_NNP )_) ._. Cells_NNP transfected_JJ with_IN the_DT
          kinase-defective_JJ IGF-IR_NNP showed_VBD a_DT more_RBR benign_JJ morphology_NN
          with_IN no_DT invasion_NN of_IN the_DT capsule_NN (_( Panel_NNP C_NNP and_CC data_NNS not_RB
          shown_VBN )_) ._. Very_RB few_JJ apoptotic_JJ cells_NNS are_VBP seen_VBN in_IN the_DT CHO_NNP
          parental_JJ and_CC CHO-WT_NNP cells_NNS ,_, whereas_IN apoptotic_JJ cells_NNS are_VBP
          seen_VBN throughout_IN the_DT tumor_NN from_IN the_DT kinase-defective_JJ
          CHO-MK_NNP cells_NNS ._. These_DT results_NNS confirm_VBP that_IN the_DT kinase_NN
          defective_JJ IGF-IR_NNP is_VBZ able_JJ to_TO inhibit_VB tumor_NN growth_NN in_IN a_DT
          model_NN system_NN ._.
        
        
          An_DT inhibitory_NN antibody_NN to_TO the_DT IGF-IR_NNP inhibits_NNS
          growth_NN of_IN U_NNP 87_CD tumors_NNS
          Adenoviral_NNP expression_NN of_IN wild-type_JJ PTEN_NNP can_MD inhibit_VB
          U_NNP 87_CD tumor_NN growth_NN indicating_VBG that_WDT elevated_VBD PI-_NNP 3_CD Kinase_NNP
          signaling_VBG is_VBZ responsible_JJ for_IN the_DT increased_VBN proliferation_NN
          and_CC survival_NN of_IN these_DT cells_NNS [_NN 47_CD 54_CD ]_NN ._. Our_PRP$ subsequent_JJ
          studies_NNS were_VBD designed_VBN to_TO test_VB whether_IN interruption_NN of_IN an_DT
          upstream_JJ growth_NN factor_NN signal_NN would_MD have_VB the_DT same_JJ growth_NN
          inhibitory_NN effect_NN as_IN reintroduction_NN of_IN PTEN_NNP ._. To_TO test_VB
          initially_RB whether_IN the_DT PTEN-deficient_NNP U_NNP 87_CD glioma_NN cells_NNS
          might_MD be_VB susceptible_JJ to_TO inhibition_NN of_IN the_DT IGF-IR_NNP ,_, we_PRP
          measured_VBD colony_NN formation_NN and_CC tumor_NN growth_NN in_IN the_DT
          presence_NN of_IN an_DT inhibitory_NN antibody_NN to_TO the_DT human_JJ IGF-IR_NNP
          (_( αIR_NN 3_LS )_) ._. This_DT antibody_NN prevents_VBZ binding_JJ of_IN IGF-I_NNP or_CC IGF-II_NNP
          to_TO the_DT extracellular_NN domain_NN of_IN the_DT IGF-IR_NNP ,_, and_CC has_VBZ been_VBN
          shown_VBN to_TO prevent_VB the_DT formation_NN of_IN MDA_NNP 231_CD tumors_NNS in_IN nude_JJ
          mice_NNS [_NN 55_CD ]_NN ._. U_NNP 87_CD cells_NNS were_VBD plated_JJ in_IN soft_JJ agar_NN in_IN the_DT
          presence_NN of_IN αIR_NN 3_CD or_CC a_DT control_NN antibody_NN ._. Cells_NNP were_VBD
          cultured_JJ for_IN 14_CD days_NNS and_CC the_DT number_NN of_IN colonies_NNS counted_VBN ._.
          The_DT presence_NN of_IN the_DT inhibitory_NN antibody_NN reduced_VBD the_DT
          number_NN of_IN colonies_NNS growing_VBG in_IN soft_JJ agar_NN but_CC the_DT control_NN
          antibody_NN had_VBD no_DT effect_NN (_( Table_NNP 1_LS )_) ._. U_NNP 87_CD cells_NNS were_VBD then_RB
          injected_VBN into_IN nude_JJ mice_NNS as_IN before_RB ._. Mice_NNS received_VBD biweekly_RB
          intraperitoneal_NN injections_NNS of_IN 100_CD μg_NN of_IN αIR_NN 3_CD or_CC control_NN
          antibody_NN starting_VBG 3_CD days_NNS after_IN injection_NN of_IN the_DT cells_NNS ._.
          The_DT αIR_NN 3_CD injections_NNS reduced_VBD the_DT number_NN of_IN tumors_NNS by_IN
          >_NN 60_CD %_NN (_( Table_NNP 1_LS )_) ._. The_DT tumors_NNS were_VBD excised_VBN ,_, fixed_VBN and_CC
          stained_JJ for_IN apoptosis_NNS ._. Tumors_NNP from_IN mice_NNS treated_VBN with_IN the_DT
          αIR_NN 3_CD antibody_NN showed_VBD extensive_JJ apoptosis_NNS unlike_IN control_NN
          tumors_NNS (_( Figure_NN 3_LS )_) ._. These_DT results_NNS confirm_VBP that_DT inhibition_NN
          of_IN IGF-I_NNP signaling_VBG by_IN an_DT inhibitory_NN antibody_NN can_MD suppress_VB
          growth_NN of_IN a_DT PTEN-deficient_NNP glioma_NN cell_NN line_NN ._.
        
        
          Retroviral_NNP expression_NN of_IN the_DT kinase_NN inactive_JJ IGF-I_NNP
          Receptor_NNP inhibits_NNS growth_NN of_IN U_NNP 87_CD glioblastoma_NN cells_NNS
          in-vivo_JJ
          To_TO make_VB expression_NN of_IN kinase_NN defective_JJ IGF-I_NNP receptors_NNS
          in_IN different_JJ cell_NN lines_NNS more_RBR tractable_JJ ,_, we_PRP generated_VBD
          pseudotyped_JJ retroviruses_NNS expressing_VBG either_CC the_DT
          kinase-defective_JJ (_( MK_NNP )_) or_CC wild-type_JJ (_( WT_NNP )_) IGF-I_NNP receptors_NNS ._.
          We_PRP also_RB obtained_VBD a_DT virus_NN expressing_VBG the_DT
          beta-galactosidase_JJ (_( LacZ_NNP )_) protein_NN to_TO measure_VB infection_NN
          efficiency_NN and_CC serve_VB as_IN a_DT virus_NN control_NN ._. U_NNP 87_CD cells_NNS were_VBD
          infected_VBN with_IN the_DT MK_NNP ,_, WT_NNP or_CC LacZ_NNP viruses_NNS and_CC selected_VBN
          with_IN G_NNP 418_CD ._. Pools_NNP of_IN cells_NNS containing_VBG stably_RB integrated_VBN
          retroviruses_NNS were_VBD then_RB used_VBN in_IN transformation_NN and_CC tumor_NN
          growth_NN experiments_NNS ._. Binding_NNP studies_NNS showed_VBD that_IN the_DT
          U_NNP 87_CD -_: LacZ_NNP cells_NNS express_VBP 10_CD 5_CD endogenous_JJ IGF-IRs_NNP per_IN cell_NN ,_,
          while_IN the_DT U_NNP 87_CD -_: WT_NNP and_CC U_NNP 87_CD -_: MK_NNP cells_NNS express_VBP 3_CD ×_NN 10_CD 6_CD and_CC 2_CD ×_NN
          10_CD 6_CD receptors_NNS per_IN cells_NNS respectively_RB ._. Thus_RB ,_, the_DT
          retrovirus_JJ allows_VBZ 20_CD to_TO 30_CD -_: fold_VB overexpression_NN of_IN the_DT
          transfected_JJ receptor_NN ._.
          To_TO test_VB the_DT function_NN of_IN the_DT virally_RB encoded_JJ receptors_NNS ,_,
          we_PRP measured_VBD IGF-I_NNP stimulated_VBN autophosphorylation_NN of_IN the_DT
          IGF-IR_NNP and_CC phosphorylation_NN of_IN IRS-_NNP 1_CD ._. Phosphorylation_NNP
          IRS-_NNP 1_CD was_VBD evident_JJ in_IN the_DT LacZ_NNP infected_JJ cells_NNS but_CC little_JJ
          IGF-IR_NNP phosphorylation_NN was_VBD seen_VBN as_IN the_DT cells_NNS express_VBP few_JJ
          receptors_NNS (_( Figure_NN 4_LS )_) ._. Infection_NNP with_IN the_DT WT_NNP virus_NN leads_VBZ
          to_TO a_DT large_JJ increase_NN in_IN IGF-IR_NNP and_CC IRS-_NNP 1_CD tyrosine_NN
          phosphorylation_NN ._. Infection_NNP with_IN the_DT MK_NNP virus_NN eliminated_VBD
          the_DT IGF-I_NNP stimulated_VBN phosphorylation_NN of_IN IRS-_NNP 1_CD confirming_VBG
          that_IN the_DT expressed_VBN receptor_NN was_VBD acting_VBG as_IN a_DT dominant_JJ
          negative_NN to_TO inhibit_VB the_DT endogenous_JJ receptors_NNS ._. The_DT
          dominant_JJ negative_JJ effect_NN is_VBZ much_RB greater_JJR in_IN these_DT cells_NNS
          than_IN the_DT CHO_NNP cells_NNS (_( Figure_NN 1_LS )_) as_IN the_DT virus_NN expresses_VBZ the_DT
          transfected_JJ receptors_NNS at_IN a_DT much_RB higher_JJR level_NN ._.
          The_DT three_CD infected_JJ U_NNP 87_CD glioma_NN cells_NNS were_VBD then_RB injected_VBN
          into_IN nude_JJ mice_NNS ._. Eight_CD to_TO twelve_CD mice_NNS were_VBD studied_VBN for_IN
          each_DT cell_NN line_NN and_CC each_DT mouse_NN received_VBD two_CD injections_NNS ._. In_IN
          two_CD different_JJ experiments_NNS ,_, mice_NNS were_VBD inoculated_JJ with_IN 10_CD
          6_CD or_CC 5_CD ×_NN 10_CD 5_CD cells_NNS ._. Tumors_NNP were_VBD excised_VBN after_IN 6_CD or_CC 10_CD
          weeks_NNS and_CC weighed_VBD (_( Table_NNP 2_LS )_) ._. The_DT WT-infected_NNP cells_NNS had_VBD
          the_DT highest_JJS frequency_NN of_IN tumor_NN formation_NN and_CC the_DT
          MK-infected_NNP cells_NNS the_DT lowest_JJS in_IN both_DT cases_NNS ._. WT-infected_NNP
          cells_NNS gave_VBD the_DT largest_JJS tumors_NNS in_IN both_DT experiments_NNS
          demonstrating_VBG that_DT overexpression_NN of_IN the_DT IGF-IR_NNP in_IN a_DT
          malignant_JJ cell_NN can_MD enhance_VB tumor_NN formation_NN as_IN we_PRP observed_VBD
          for_IN the_DT CHO_NNP cells_NNS ._. The_DT MK-infected_NNP cells_NNS gave_VBD fewer_JJR
          tumors_NNS in_IN both_DT experiments_NNS ,_, but_CC more_RBR importantly_RB ,_, those_DT
          tumors_NNS that_WDT did_VBD form_NN were_VBD much_RB smaller_JJR ._. The_DT results_NNS
          obtained_VBN with_IN the_DT dominant_JJ negative_JJ IGF-IR_NNP are_VBP identical_JJ
          to_TO published_VBN results_NNS reintroducing_VBG PTEN_NNP ,_, hence_RB ,_,
          inhibition_NN of_IN upstream_RB PI-_NNP 3_CD Kinase_NNP signaling_VBG might_MD be_VB a_DT
          useful_JJ approach_NN for_IN PTEN-deficient_NNP tumors_NNS ._.
          The_DT tumors_NNS were_VBD imbedded_JJ in_IN paraffin_NN and_CC sections_NNS were_VBD
          stained_JJ with_IN hematoxylin_NN and_CC eosin_NN (_( Figure_NN 5_LS )_) ._. The_DT
          U_NNP 87_CD -_: LacZ_NNP tumors_NNS are_VBP very_RB cellular_JJ with_IN small_JJ regular_JJ
          nuclei_NN (_( left_VBD panel_NN )_) and_CC show_VB some_DT invasion_NN of_IN the_DT capsule_NN
          by_IN tumor_NN cells_NNS (_( right_JJ panel_NN )_) ._. The_DT tumors_NNS from_IN U_NNP 87_CD cells_NNS
          infected_VBN with_IN the_DT IGF-IR_NNP virus_NN are_VBP also_RB very_RB cellular_JJ ,_,
          but_CC the_DT cells_NNS have_VBP larger_JJR nuclei_NN (_( left_VBD panel_NN )_) and_CC have_VBP
          completely_RB invaded_VBD the_DT capsule_NN (_( right_JJ panel_NN )_) ._. The_DT tumors_NNS
          from_IN U_NNP 87_CD cells_NNS infected_VBN with_IN the_DT kinase_NN inactive_JJ IGF-IR_NNP
          are_VBP less_RBR cellular_JJ with_IN larger_JJR areas_NNS of_IN stroma_NN (_( left_VBD
          panel_NN )_) ._. Numerous_JJ irregular_JJ nuclei_NN are_VBP apparent_JJ ._. There_EX is_VBZ
          no_DT invasion_NN of_IN the_DT capsule_NN by_IN tumor_NN cells_NNS (_( right_JJ panel_NN )_) ._.
          The_DT irregular_JJ nuclei_NN and_CC intact_JJ capsule_NN are_VBP consistent_JJ
          with_IN data_NNS from_IN other_JJ cells_NNS showing_VBG that_DT inhibition_NN of_IN
          IGF-IR_NNP expression_NN causes_VBZ apoptosis_NNS and_CC prevents_VBZ
          metastasis_NNS ._.
          The_DT idea_NN that_IN the_DT IGF-IR_NNP might_MD be_VB a_DT valuable_JJ target_NN
          for_IN the_DT treatment_NN of_IN brain_NN tumors_NNS is_VBZ supported_VBN by_IN a_DT
          recent_JJ pilot_NN study_NN in_IN twelve_CD patients_NNS with_IN malignant_JJ
          astrocytomas_NNS [_NN 56_CD ]_NN ._. All_DT patients_NNS had_VBD grade_NN 3_CD or_CC 4_CD
          astrocytomas_NNS and_CC had_VBD failed_VBN on_IN standard_JJ therapy_NN ._. The_DT PTEN_NNP
          status_NN of_IN their_PRP$ primary_JJ tumors_NNS was_VBD not_RB known_VBN ._. After_IN
          surgery_NN ,_, autologous_JJ glioma_NN cells_NNS were_VBD collected_VBN and_CC
          treated_VBN ex-vivo_JJ with_IN IGF-IR_NNP antisense_NN oligos_NNS and_CC
          re-implanted_JJ in_IN diffusion_NN chambers_NNS for_IN 24_CD h_NN ._. Clinical_NNP and_CC
          radiological_JJ improvements_NNS were_VBD seen_VBN in_IN eight_CD of_IN the_DT
          twelve_CD patients_NNS ._. Five_CD patients_NNS showed_VBD a_DT lymphocytic_JJ
          infiltration_NN after_IN antisense_NN treatment_NN indicating_VBG that_IN
          knocking_VBG out_RP the_DT IGF-IR_NNP induced_VBD an_DT immune_JJ response_NN ._. It_PRP
          would_MD be_VB interesting_JJ to_TO determine_VB whether_IN response_NN to_TO
          this_DT treatment_NN correlated_JJ with_IN loss_NN of_IN PTEN_NNP in_IN the_DT
          primary_JJ tumors_NNS ._.
        
      
      
        Conclusions_NNP
        Loss_NN of_IN PTEN_NNP is_VBZ a_DT very_RB common_JJ occurrence_NN in_IN human_JJ
        tumors_NNS ._. Restoring_NNP PTEN_NNP protein_NN or_CC function_NN to_TO reduce_VB
        PI-_NNP 3_CD Kinase_NNP signaling_VBG prevents_VBZ tumor_NN growth_NN in_IN animal_NN
        models_NNS ._. However_RB ,_, it_PRP may_MD not_RB be_VB possible_JJ to_TO restore_VB PTEN_NNP in_IN
        human_JJ tumors_NNS ._. Direct_JJ inhibition_NN of_IN PI-_NNP 3_CD Kinase_NNP activity_NN may_MD
        not_RB be_VB feasible_JJ either_CC as_IN it_PRP is_VBZ likely_JJ to_TO have_VB severe_JJ side_NN
        effects_NNS ._. Our_PRP$ results_NNS suggest_VBP that_IN a_DT therapeutic_JJ strategy_NN to_TO
        inhibit_VB the_DT upstream_JJ stimulus_NN for_IN PI-_NNP 3_CD Kinase_NNP through_IN
        blockade_NN of_IN growth_NN factor_NN receptors_NNS may_MD provide_VB a_DT workable_JJ
        alternative_NN ._.
      
      
        Abbreviations_NNP
        PIP_NNP 3_CD :_: Phosphatidyl-_NNP 3_CD ,_, 4_CD ,_, 5_CD -_: triphosphate_NN ;_: DMEM_NNP :_: Dulbecco_NNP 's_POS
        Modified_NNP Eagle_NNP 's_POS Medium_NNP ;_: PI-_NNP 3_CD Kinase_NNP :_:
        phosphatidylinositol-_NN 3_CD -_: kinase_NN ;_: MAPK_NNP :_: mitogen-activated_JJ
        protein_NN kinase_NN ;_: IGF_NNP :_: insulin-like_JJ growth_NN factor_NN ;_: PTEN_NNP :_:
        phosphatase_NN and_CC tensin_NN homolog_NN deleted_VBN from_IN chromosome_NN 10_CD ;_:
        SOS_NNP :_: son-of-sevenless_JJ ras_NNS exchange_VBP factor_NN ;_: ASK_NNP :_: apoptosis_NNS
        stimulating_VBG kinase_NN ;_: FKHR_NNP :_: forkhead_NN related_VBD protein_NN ;_: cFLIP_NN :_:
        cellular_JJ FLICE_NNP interacting_VBG protein_NN ;_: BSA_NNP :_: bovine_JJ serum_NN
        albumin_NN ;_: TBS_NNP :_: tris_NNS buffered_JJ saline_NN ;_: PVDF_NNP :_: polyvinylidene_NN
        difluoride_NN
      
      
        Competing_VBG Interests_NNP
        None_NN declared_VBD ._.
      
      
        Author_NN Contributions_NNP
        B_NNP ._. L_NNP ._. S_NNP ._. conducted_VBD the_DT studies_NNS on_IN CHO_NNP cells_NNS and_CC the_DT
        inhibitory_NN antibody_NN studies_NNS on_IN U_NNP 87_CD cells_NNS ._. G_NNP ._. S_NNP ._. performed_VBD
        the_DT tumor_NN growth_NN studies_NNS with_IN the_DT U_NNP 87_CD cells_NNS ._. N_NNP ._. J_NNP ._. G_NNP ._. W_NNP ._.
        constructed_VBN the_DT pseudotyped_JJ retroviruses_NNS and_CC drafted_VBD the_DT
        manuscript_NN ._.
      
    
  
